1. Developmental and reproductive safety evaluation of AV7909 anthrax vaccine candidate in rats
- Author
-
Jeffry D. Shearer, Bruna Blauth, Jeff D Ballin, Eve Mylchreest, Joshua J. Reece, M. Autumn Smiley, Boris Ionin, and Vladimir Savransky
- Subjects
0301 basic medicine ,reproductive toxicity ,Embryology ,anthrax vaccine ,Health, Toxicology and Mutagenesis ,medicine.medical_treatment ,Developmental toxicity ,Physiology ,Anthrax Vaccines ,030105 genetics & heredity ,Toxicology ,Anthrax ,Rats, Sprague-Dawley ,03 medical and health sciences ,Pregnancy ,medicine ,Animals ,developmental toxicity ,rat ,Research Articles ,Anthrax vaccines ,business.industry ,Reproduction ,Anthrax Vaccine Adsorbed ,medicine.disease ,Antibodies, Neutralizing ,Rats ,Vaccination ,AV7909 ,030104 developmental biology ,Pediatrics, Perinatology and Child Health ,Female ,Reproductive toxicity ,business ,Intramuscular injection ,Adjuvant ,Developmental Biology ,Research Article - Abstract
The AV7909 vaccine, consists of the Anthrax Vaccine Adsorbed (AVA) bulk drug substance and the immunostimulatory Toll‐like receptor 9 agonist oligodeoxynucleotide adjuvant CPG 7909. The purpose of this research was to evaluate the potential maternal, reproductive, and developmental toxicity of AV7909 in rats to support licensure for use in women of childbearing potential. Groups of first generation (F0) female Sprague Dawley rats were dosed by intramuscular injection with water for injection, adjuvant or AV7909 at a volume of 0.5 ml/dose. Each rat received three vaccinations: 14 days prior to start of the mating period, on the first day of the mating period and on gestation day (GD) 7. There was no maternal mortality. Body weights, weight gain, and food consumption were comparable between groups. Findings in F0 females were limited to transient injection site edema and nodules consistent with immunostimulatory effects of the vaccine and adjuvant. Administration of AV7909 did not affect mating, fertility, pregnancy, embryo‐fetal viability, growth, or morphologic development, parturition, maternal care of offspring or postnatal survival, growth, or development. There was no evidence of systemic inflammation in pregnant rats, based on evaluation of serum concentrations of the acute phase proteins alpha‐2‐macroglobulin and alpha‐1‐acid glycoprotein on GD 21. Anthrax lethal toxin‐neutralizing antibodies were detected in AV7909‐vaccinated F0 females. The antibodies were also detected in the sera of fetuses and F1 pups. Exposure of the fetuses and pups to maternally derived anthrax lethal toxin‐neutralizing antibodies was not associated with developmental toxicity.
- Published
- 2020